Pushing the Frontiers of Neuroscience with GE Healthcare’s SIGNA MAGNUS

Monday, May 06, 2024

GE HealthCare recently unveiled SIGNA MAGNUS, a head-only magnetic resonance (MR) scanner targeting advancements in neuroscience research.

Addresses limitations in conventional whole-body MR systems, hindering progress in understanding psychiatric diseases and neurological disorders like Alzheimer's. Currently, only a fraction of those with neurological disorders worldwide can be diagnosed via MRI, underscoring the pressing need to expand MRI's clinical applications in neuroscience.

SIGNA MAGNUS, GE HealthCare's cutting-edge 3.0T MR imaging device, is tailored for superior performance in neurological and oncological research, particularly for head-only imaging. It promises enhanced detail and clarity to delve into the intricacies of brain microstructure, microvasculature, and function.

Through this innovation, GE HealthCare aims to empower neuroscientists, neurologists, neuroradiologists, and oncologists to overcome existing barriers in diagnosing, understanding, and treating complex diseases.

SIGNA MAGNUS isn't just a tool but a milestone in medical research and future clinical care. The system boasts HyperG gradient technology, offering unparalleled gradient performance with 300 mT/m and 750 T/m/s capabilities, enabling the detection of finer details previously unattainable.

Researchers can leverage its capabilities, alongside GE HealthCare's latest deep-learning algorithms, to push the boundaries of advanced anatomical, diffusion, and functional techniques.

The innovative asymmetric gradient design of SIGNA MAGNUS facilitates exceptional diffusion performance, achieving high B-value diffusion with short echo times (TEs), enhancing the understanding of neural architecture.

The system offers upgradability for many existing GE HealthCare 3.0T systems, providing cost-saving opportunities for potential customers.

In March 2024, the investigational MAGNUS system was successfully installed at Brigham and Women's Hospital, a renowned research institution. Collaborating with the Brigham team, GE HealthCare aims to unlock new research opportunities in high-performance neuro, the project's principal investigator, highlights the system's potential to measure previously unattainable metrics and pose novel research questions.

GE HealthCare's commitment to innovation and collaboration continues to shape the landscape of medical research and healthcare delivery, translating scientific advancements into meaningful health outcomes for patients globally.


Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare Innovation & Transformation SummitHealthcare CNO SummitHealthcare CMO SummitThe Healthcare Patient Experience & Engagement Summit 2024